CATALOGO DEI PRODOTTI DELLA RICERCA

MATTE', Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.001
NA - Nord America 2.432
AS - Asia 2.044
SA - Sud America 339
AF - Africa 42
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.867
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.380
RU - Federazione Russa 1.258
SG - Singapore 776
CN - Cina 651
GB - Regno Unito 632
BR - Brasile 282
IT - Italia 259
VN - Vietnam 217
SE - Svezia 175
HK - Hong Kong 174
FR - Francia 143
IE - Irlanda 141
DE - Germania 135
FI - Finlandia 107
JP - Giappone 49
UA - Ucraina 38
ID - Indonesia 37
KR - Corea 32
AR - Argentina 29
IN - India 25
CA - Canada 24
AT - Austria 23
MX - Messico 23
NL - Olanda 21
BE - Belgio 16
ES - Italia 13
TR - Turchia 12
PL - Polonia 10
TW - Taiwan 9
BD - Bangladesh 8
EC - Ecuador 8
EG - Egitto 8
BJ - Benin 7
IQ - Iraq 7
UZ - Uzbekistan 6
ZA - Sudafrica 6
AU - Australia 5
GR - Grecia 5
OM - Oman 5
PK - Pakistan 5
TG - Togo 5
CL - Cile 4
CZ - Repubblica Ceca 4
JO - Giordania 4
KG - Kirghizistan 4
LT - Lituania 4
MA - Marocco 4
NG - Nigeria 4
PY - Paraguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
CH - Svizzera 3
CO - Colombia 3
DZ - Algeria 3
NP - Nepal 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
EU - Europa 2
IL - Israele 2
KH - Cambogia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
RO - Romania 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DK - Danimarca 1
GE - Georgia 1
GH - Ghana 1
HU - Ungheria 1
IR - Iran 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
SZ - Regno dello Swaziland 1
TN - Tunisia 1
VC - Saint Vincent e Grenadine 1
ZW - Zimbabwe 1
Totale 7.867
Salva come PNG Salva come JPEG
Città #
Southend 538
Moscow 429
Singapore 372
Chandler 340
Dallas 234
Ashburn 214
Jacksonville 188
Hong Kong 170
Ann Arbor 154
Dublin 141
Beijing 132
Verona 115
Houston 88
Woodbridge 78
Wilmington 69
Dong Ket 57
New York 56
The Dalles 52
Lawrence 50
Princeton 50
Los Angeles 49
Ho Chi Minh City 48
Jinan 48
Tokyo 43
Nanjing 39
Jakarta 36
Helsinki 34
Hebei 32
Shenyang 31
Munich 28
São Paulo 28
Buffalo 25
Hanoi 21
Lancaster 19
Redondo Beach 19
Collegeville 18
Council Bluffs 18
Falls Church 18
Ningbo 18
Changsha 17
Columbus 17
Redmond 17
Seattle 17
Sindelfingen 17
Boardman 16
Brussels 16
Hangzhou 16
London 16
Milan 16
Nanchang 16
Turku 16
Vienna 16
Zhengzhou 16
Guangzhou 15
Tianjin 15
Nuremberg 14
Montreal 12
Santa Clara 12
Taiyuan 12
San Francisco 11
Chicago 10
Haikou 10
Jiaxing 10
Stockholm 10
Campinas 9
Taizhou 9
Frankfurt am Main 8
San Jose 8
Warsaw 8
Belo Horizonte 7
Bologna 7
Chennai 7
Cotonou 7
Lanzhou 7
Redwood City 7
Rome 7
Cagliari 6
Cambridge 6
Catanzaro 6
Dongguan 6
Manchester 6
Mexico City 6
Norwalk 6
Orem 6
Toronto 6
Atlanta 5
Brooklyn 5
Cairo 5
Cincinnati 5
Denver 5
Fairfield 5
Falkenstein 5
Fuzhou 5
Goiânia 5
Guarulhos 5
Johannesburg 5
Lappeenranta 5
Lomé 5
Phoenix 5
Renton 5
Totale 4.679
Salva come PNG Salva come JPEG
Nome #
Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease 272
Impaired pro‐resolving mechanisms promote abnormal NETosis , fueling autoimmunity in sickle cell disease 234
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 221
Fyn kinase is a novel modulator of erythropoietin signaling and stress erythropoiesis. 214
Two-photon microscopy imaging of thy1GFP-M transgenic mice: a novel animal model to investigate brain dendritic cell subsets in vivo 202
A new molecular link between defective autophagy and erythroid abnormalities in chorea-acanthocytosis 198
TREATMENT OF SKELETAL DISEASES WITH A NATURALLY DERIVED ANTIOXIDANT AND BISPHOSPHONATE EMBEDDED NANOPARTICLES 192
A Selective Oral GLYT1 Inhibitor, Improves Anemia and Red Cell Survival in a Mouse Model of Beta-Thalassemia 189
Protease inhibitors-based therapy induces acquired spherocytic-like anemia and ineffective erythropoiesis in chronic HCV patients 175
Band 3 Erythrocyte Membrane Protein Acts as Redox Stress Sensor Leading to Its Phosphorylation by p (72) Syk 164
Heat shock protein-27, 70 and peroxiredoxin-II show molecular chaperone function in sickle red cells: evidences from transgenic sickle cell mouse model 163
Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band3 163
The interplay between peroxiredoxin-2 and Nrf2 is important in limiting oxidative mediated dysfunction in b-thalassemic erythropoiesis 161
Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity 160
Oxidative stress and b-thalasssemic erythroid cells behind the molecular defect 159
New Therapeutic Options for the Treatment of Sickle Cell Disease. 158
IN ChAc RED CELLS THE ABNORMALLY ACTIVATED LYN AFFECTS ANKYRIN MULTIPROTEIN COMPLEXES AND IS INHIBITED BY DASATINIB 157
Peroxiredoxin-2: A Novel Factor Involved in Iron Homeostasis 156
Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis. 154
Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis 154
Factor H interfers with the adhesion of sickle red cells to vascular endothelium: a novel disease modulating molecule 153
S-nitrosylation of peroxiredoxin II E promotes peroxynitrite-mediated tyrosine nitration 152
Integrated proteomic analysis of normal and diseased red cells. Role of physiological stresses in erythrocyte signaling pathways 150
Dietary w-3 fatty acids protect against vasculopathy in a transgenic mouse model for sickle cell disease. 150
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 149
Proteomic analysis of S-nitrosylated proteins in Arabidopsis thaliana undergoing hypersensitive response 142
Deoxygenation affects tyrosine phosphoproteome of red cell membrane from patients with sickle cell disease 142
Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice 140
Emerging drugs in randomized controlled trials for sickle cell disease: are we on the brink of a new era in research and treatment? 139
The novel role of peroxiredoxin-2 in red cell membrane protein homeostasis and senescence. 131
Increased levels of ERFE-encoding FAM132B in patients with congenital dyserythropoietic anemia type II 130
NCOA4 Deficiency Impairs Systemic Iron Homeostasis 130
Proteomic and functional analysis of tyrosinephosphorylated red cell membrane proteins in mouse lacking SRC-family-kinases 130
Pharmacological inhibition of calpain-1 prevents red cell dehydration and reduces Gardos channel activity in a mouse model of sickle cell disease 129
Performance of a novel sieving matrix of Poly(vinyl alcohol)ACRYLAMIDE copolymer in elecrophoretic separations of high molecular weight proteins from red cell membrane. 122
Effects of hypoxia–reoxygenation stimuli on renal redox status and nuclear factor erythroid 2-related factor 2 pathway in sickle cell SADmice 121
Tyrosine phosphorylation modulates peroxiredoxin-2 activity in normal and diseased red cells 121
Oxidized and poorly glycosylated band 3 is selectively phosphorylated by Syk kinase to form large membrane clusters in normal and G6PD-deficient red blood cells 119
Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension 119
Fyn specifically Regulates the activity of red cell glucose-6-phosphate-dehydrogenase 119
Adaptative Up-Regulation of PRX2 and PRX5 Expression Characterizes Brain from a Mouse Model of Chorea-Acanthocytosis 118
Oxidation and erythropoiesis 118
Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia 116
The Novel Role That Nrf2 Plays in Erythropoiesis during Aging 116
Resolvin D1 and Resolvin D2 Protect Against Hypoxia/Reoxygenation Induced Lung and Kidney Damage in a Sickle Cell Mouse Model of Acute Vaso-Occlusive Crisis 115
Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1. 113
Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversible by blood transfusion 112
Peroxiredoxin-2 (Prx2) expression is increased in beta thalassemic mouse red cells but displaced from the membrane as marker of oxidative stress 110
Epeleuton, a novel synthetic ω-3 fatty acid, reduces hypoxia/ reperfusion stress in a mouse model of sickle cell disease 104
Pesticide toxicogenomics across scales: in vitro transcriptome predicts mechanisms and outcomes of exposure in vivo 103
An Oral Carbon Monoxide-Releasing Molecule Protects against Acute Hyper-hemolysis in Sickle Cell Disease 98
Oxidation Impacts the Intracellular Signaling Machinery in Hematological Disorders 96
Red Blood Cell Homeostasis: Pharmacological Interventions to Explore Biochemical, Morphological and Mechanical Properties. 91
Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder 79
Mitapivat metabolically reprograms human beta-thalassemic erythroblasts, increasing their responsiveness to oxidation 73
Pharmacological Inhibition of Calpain-1 Prevents Red Cell Dehydration and Reduces Gardos Channel Activity in a Mouse Model of Sickle Cell Disease. Identification of Druggable Protease Target 41
PEROXIREDOXIN-2 (Prx2) MEMBRANE DISPLACEMENT IS A NEW ADDITIONAL FACTOR to the SEVERITY of beta-THALASSEMIC MOUSE RED CELL MEMBRANE DAMAGE 35
Totale 7.972
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.407
article - articoli 21.804
book - libri 0
conference - conferenze 3.199
curatela - curatele 0
other - altro 404
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.814
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021258 0 0 0 0 0 44 17 14 13 7 54 109
2021/2022444 32 130 14 34 21 11 14 25 35 17 18 93
2022/2023983 62 132 82 150 90 240 8 37 98 33 32 19
2023/2024536 22 40 39 61 66 78 25 35 9 14 109 38
2024/20251.426 76 64 49 242 77 96 129 69 209 81 100 234
2025/20262.578 264 176 246 572 1.069 251 0 0 0 0 0 0
Totale 7.972